LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 171 filers reported holding LEGEND BIOTECH CORP in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,843,959 | -13.5% | 72,072 | -11.1% | 1.15% | -4.3% |
| Q2 2023 | $5,600,853 | +6.1% | 81,113 | -25.8% | 1.20% | +3.0% |
| Q1 2023 | $5,280,801 | +4.0% | 109,356 | +7.0% | 1.17% | +2.3% |
| Q4 2022 | $5,077,324 | +36.4% | 102,180 | +12.1% | 1.14% | +32.7% |
| Q3 2022 | $3,722,000 | -31.7% | 91,128 | -8.0% | 0.86% | -25.1% |
| Q2 2022 | $5,453,000 | +46.2% | 99,008 | -3.5% | 1.15% | +105.4% |
| Q1 2022 | $3,729,000 | +3.0% | 102,644 | +32.1% | 0.56% | +18.4% |
| Q4 2021 | $3,619,000 | – | 77,718 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |